Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Crownlands Observing Progression With Neurons I (CROWN-I)
Authors not listed
Crownlands · 2026
Abstract
The CROWN-I Study is an observational study to learn about molecular features of Alzheimer's disease (AD) and mild cognitive impairment (MCI). The primary objective is to identify the molecular and genetic modules that differentiate patient subtypes and predict progression of AD. Participants will visit clinical sites to donate samples multiple times and perform virtual and in-person clinical assessments.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2026). Crownlands Observing Progression With Neurons I (CROWN-I). <em>Crownlands</em>. https://clinicaltrials.gov/study/NCT07611396
Vancouver
Anonymous. Crownlands Observing Progression With Neurons I (CROWN-I). Crownlands. 2026.
BibTeX
@misc{anon2026Crownl,
title = {Crownlands Observing Progression With Neurons I (CROWN-I)},
author = {Anonymous},
journal = {Crownlands},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
AbbVie 2015
Open access · US-GOV
A Study to Evaluate the Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of Multiple Doses of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment Due to Alzheimer's Disease
Posit Science Corporation 2004
Open access · US-GOV
Computer-Based Training for Mild Cognitive Impairment and Mild Alzheimer's Disease
Universitaire Ziekenhuizen KU Leuven 2026
Open access · US-GOV
The Diagnostic Validity and Clinical Impact of Blood-based Biomarkers for the Diagnosis of Alzheimer's Disease at the Primary Care Level.
Drug Design Development and Therapy 2017
Open access · CC-BY
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
University Hospital, Strasbourg, France 2012
Open access · US-GOV
Evaluation of fMRI-SAM in the Early Detection of Alzheimer's Disease.
University of Udine 2024
Open access · US-GOV